Citadel Advisors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Citadel Advisors's OGN Position: Q1 2026 in Review
Citadel Advisors reduced its Organon & Co (OGN) stake by 3.1% in Q1 2026, selling an estimated $486K and leaving 1,998,390 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #3008.
Citadel Advisors first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $116M in Q1 2024. 604 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Citadel Advisors held 1,998,390 shares of Organon & Co worth $12M as of Q1 2026.
- Citadel Advisors sold 64,584 Organon & Co shares in Q1 2026, an estimated $486K.
- Organon & Co made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3008 holding.
- Citadel Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
- Citadel Advisors's Organon & Co position peaked at $116M in Q1 2024.
- 604 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.